Brief: ProSomnus Announces Medicare Reimbursement For ProSomnus EVO
15/12/2022 13:36
Dec 15 (Reuters) - ProSomnus Inc OSA.O :
* PROSOMNUS® ANNOUNCES MEDICARE REIMBURSEMENT FOR PROSOMNUS
EVO®
PH SLEEP APNEA AND SNORING DEVICE
Source text for Eikon: ID:nGNX5HnfFh
Further company coverage: OSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProSomnus
See all newsBrief: Prosomnus Sleep Technologies Says Co Enters Into Voluntary Chapter 11 Restructuring Process Which Will Take Company Private, Reduce Debt
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Prosomnus Raises $10 Million To Fuel Growth And Optimize Operations
Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea